Janko Ruiz de Chávez - founder of RHC Farma 18 years ago,

New Post Public Reply Private Reply Replies (0) Message Board
letuan
1,146
Janko Ruiz de Chávez - founder of RHC Farma 18 years ago, a pharmaceutical company that was originally created to develop medicines and herbal remedies, now creator of CBD Life - for two and a half years that he proposed to introduce the first products made with base in marijuana.

He currently has 21 permits from Cofepris for sale and, among the products he manages, is mariguanol, a ünguento that is known to be sold informally on public transport such as the Metro, but which the company has already patented it to distribute it in pharmacies

In an interview, Ruiz de Chávez said that the idea of ​​developing marijuana-based medicinal products arose from noting that if he added CBD to his creations, the products could have incredible properties, so he researched in several countries around the world to Confirm it and choose the canabbis as your best source of supply.

We recommend: Cofepris grants 38 permits to manufacture cannabis products

Ruiz de Chávez also added that his sales projection for the end of 2018 is 50 million dollars (mdd) in 40,000 points of sale, in addition to that he has begun to venture into electronic commerce via Amazon. Over the next five years, the company aims to achieve sales of up to 150 million dollars.

In a projection of the future, the founder of CBD Life believes that the market value of the CBD and its pharmacists can reach up to USD 400 million in the long term, and that this will be the largest segment of the world in terms of products derived from cannabis with less of 1% Tetrahydrocannabinol (THC), the main psychoactive constituent of marijuana.
https://manufactura.mx/quimica-y-farmaceutica...-marihuana

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading